EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access

Trans -ancestry, Bayesian meta-analysis discovers 20 novel risk loci for inflammatory bowel disease in an African American, East Asian and European cohort

Roberto Y Cordero iD, Jennifer B Cordero iD, Andrew B Stiemke, Lisa W Datta, Steven Buyske iD, Subra Kugathasan, Dermot P B McGovern iD, Steven R Brant iD, Claire L Simpson iD

Human Molecular Genetics · 2023

DOI: 10.1093/hmg/ddac269 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Human Molecular Genetics, 2023. Verfasst von Roberto Y Cordero und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Genomics, and Informatics, University of Tennessee Health Science Center, Memphis, TN 38163, USA. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD) is an immune-mediated chronic intestinal disorder with major phenotypes: ulcerative colitis (UC) and Crohn’s disease (CD). Multiple studies have identified over 240 IBD susceptibility loci. However, most studies have centered on European (EUR) and East Asian (EAS) populations. The prevalence of IBD in non-EUR, including African Americans (AAs), has risen in recent years. Here we present the first attempt to identify loci in AAs using a trans-ancestry Bayesian approach (MANTRA) accounting for heterogeneity between diverse ancestries while allowing for the similarity between closely related populations. We meta-analyzed genome-wide association studies (GWAS) and Immunochip data from a 2015 EUR meta-analysis of 38 155 IBD cases and 48 485 controls and EAS Immunochip study of 2824 IBD cases and 3719 controls, and our recent AA IBD GWAS of 2345 cases and 5002 controls. Across the major IBD phenotypes, we found significant evidence for 92% of 205 loci lead SNPs from the 2015 meta-analysis, but also for three IBD loci only established in latter studies. We detected 20 novel loci, all containing immunity-related genes or genes with other evidence for IBD or immune-mediated disease relevance: PLEKHG5;TNFSFR25 (encoding death receptor 3, receptor for TNFSF15 gene product TL1A), XKR6, ELMO1, BC021024;PI4KB;PSMD4 and APLP1 for IBD; AUTS2, XKR6, OSER1, TET2;AK094561, BCAP29 and APLP1 for CD; and GABBR1;MOG, DQ570892, SPDEF;ILRUN, SMARCE1;CCR7;KRT222;KRT24;KRT25, ANKS1A;TCP11, IL7, LRRC18;WDFY4, XKR6 and TNFSF4 for UC. Our study highlights the value of combining low-powered genomic studies from understudied populations of diverse ancestral backgrounds together with a high-powered study to enable novel locus discovery, including potentially important therapeutic IBD gene targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeCrohn DiseaseInflammatory Bowel DiseasesHumansBayes TheoremBlack or African AmericanEast Asian PeopleGenetic Predisposition to DiseaseGenome-Wide Association StudyMembrane ProteinsOX40 LigandPolymorphism, Single NucleotideTumor Necrosis Factor Ligand Superfamily Member 15European PeopleChromosomal Proteins, Non-HistoneDNA-Binding Proteins

Substanzen

Membrane ProteinsOX40 LigandTumor Necrosis Factor Ligand Superfamily Member 15BCAP29 protein, humanSMARCE1 protein, humanChromosomal Proteins, Non-HistoneDNA-Binding ProteinsTNFSF15 protein, humanTNFSF4 protein, human

Autor:innen und Institutionen

  • Department of Genetics, Genomics, and Informatics, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
  • Meyerhoff Inflammatory Bowel Disease Center, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD 21231, USA.
  • Department of Statistics and Biostatistics, Rutgers University, Piscataway, NJ 08854, USA.
  • Department of Pediatrics and Department of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA.
  • F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA.
  • Rutgers Crohn's and Colitis Center of New Jersey, Department of Medicine, Rutgers Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901, USA.

ORCID-Profile: Roberto Y Cordero, Jennifer B Cordero, Steven Buyske, Dermot P B McGovern, Steven R Brant, Claire L Simpson

Förderung

  • NIDDK NIH HHS
  • National Institutes of Health

Zitieren

APA

Cordero, R. Y., Cordero, J. B., Stiemke, A. B., Datta, L. W., Buyske, S., Kugathasan, S., McGovern, D. P. B., Brant, S. R., & Simpson, C. L. (2023). Trans -ancestry, Bayesian meta-analysis discovers 20 novel risk loci for inflammatory bowel disease in an African American, East Asian and European cohort. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddac269

Vancouver

Cordero RY, Cordero JB, Stiemke AB, Datta LW, Buyske S, Kugathasan S, et al. Trans -ancestry, Bayesian meta-analysis discovers 20 novel risk loci for inflammatory bowel disease in an African American, East Asian and European cohort. Human Molecular Genetics. 2023. doi:10.1093/hmg/ddac269

BibTeX
@article{Cordero2023,
  author = {Cordero, Roberto Y and Cordero, Jennifer B and Stiemke, Andrew B and Datta, Lisa W and Buyske, Steven and Kugathasan, Subra and McGovern, Dermot P B and Brant, Steven R and Simpson, Claire L},
  title = {Trans -ancestry, Bayesian meta-analysis discovers 20 novel risk loci for inflammatory bowel disease in an African American, East Asian and European cohort},
  journal = {Human Molecular Genetics},
  year = {2023},
  doi = {10.1093/hmg/ddac269}
}
Kostenlos starten →